Home > > > Report Detail

Global Human Chorionic Gonadotropin (HCG) Market Insights, Forecast to 2025

Publisher Name :
Date: 11-Jun-2019
No. of pages: 113
Inquire Before Buying

Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.

The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.

The global Human Chorionic Gonadotropin (HCG) market is valued at 390 million US$ in 2018 and will reach 620 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Chorionic Gonadotropin (HCG) market based on company, product type, end user and key regions.

This report studies the global market size of Human Chorionic Gonadotropin (HCG) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Chorionic Gonadotropin (HCG) in these regions.

This research report categorizes the global Human Chorionic Gonadotropin (HCG) market by top players/brands, region, type and end user. This report also studies the global Human Chorionic Gonadotropin (HCG) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- EMD Serono, Inc

- Ferring B.V

- Merck & Co., Inc

- Bristol Myers Squibb Company

- Fresenius Kabi AG, LLC

- Scrippslabs

- Leebio

- Kamiya Biomedical Company

- Sanzyme

- Cigna

Market size by Product

- Natural Source Extraction

- Recombinant DNA Technology

Market size by End User

- Female Infertility Treatment

- Oligospermic Treatment

- Cryptorchidism Treatment

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Human Chorionic Gonadotropin (HCG) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Human Chorionic Gonadotropin (HCG) market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Human Chorionic Gonadotropin (HCG) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Human Chorionic Gonadotropin (HCG) submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Human Chorionic Gonadotropin (HCG) are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Chorionic Gonadotropin (HCG) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Human Chorionic Gonadotropin (HCG) Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Human Chorionic Gonadotropin (HCG) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Product
1.4.2 Natural Source Extraction
1.4.3 Recombinant DNA Technology
1.5 Market by End User
1.5.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by End User
1.5.2 Female Infertility Treatment
1.5.3 Oligospermic Treatment
1.5.4 Cryptorchidism Treatment
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Chorionic Gonadotropin (HCG) Market Size
2.1.1 Global Human Chorionic Gonadotropin (HCG) Revenue 2014-2025
2.1.2 Global Human Chorionic Gonadotropin (HCG) Sales 2014-2025
2.2 Human Chorionic Gonadotropin (HCG) Growth Rate by Regions
2.2.1 Global Human Chorionic Gonadotropin (HCG) Sales by Regions
2.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Human Chorionic Gonadotropin (HCG) Sales by Manufacturers
3.1.1 Human Chorionic Gonadotropin (HCG) Sales by Manufacturers
3.1.2 Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturers
3.1.3 Global Human Chorionic Gonadotropin (HCG) Market Concentration Ratio (CR5 and HHI)
3.2 Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers
3.2.1 Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers (2014-2019)
3.2.2 Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers (2014-2019)
3.3 Human Chorionic Gonadotropin (HCG) Price by Manufacturers
3.4 Human Chorionic Gonadotropin (HCG) Manufacturing Base Distribution, Product Types
3.4.1 Human Chorionic Gonadotropin (HCG) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Chorionic Gonadotropin (HCG) Product Type
3.4.3 Date of International Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Human Chorionic Gonadotropin (HCG) Sales by Product
4.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Product
4.3 Human Chorionic Gonadotropin (HCG) Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Human Chorionic Gonadotropin (HCG) Breakdown Data by End User
6 North America
6.1 North America Human Chorionic Gonadotropin (HCG) by Countries
6.1.1 North America Human Chorionic Gonadotropin (HCG) Sales by Countries
6.1.2 North America Human Chorionic Gonadotropin (HCG) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Human Chorionic Gonadotropin (HCG) by Product
6.3 North America Human Chorionic Gonadotropin (HCG) by End User
7 Europe
7.1 Europe Human Chorionic Gonadotropin (HCG) by Countries
7.1.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Countries
7.1.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Chorionic Gonadotropin (HCG) by Product
7.3 Europe Human Chorionic Gonadotropin (HCG) by End User
8 Asia Pacific
8.1 Asia Pacific Human Chorionic Gonadotropin (HCG) by Countries
8.1.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Countries
8.1.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Human Chorionic Gonadotropin (HCG) by Product
8.3 Asia Pacific Human Chorionic Gonadotropin (HCG) by End User
9 Central & South America
9.1 Central & South America Human Chorionic Gonadotropin (HCG) by Countries
9.1.1 Central & South America Human Chorionic Gonadotropin (HCG) Sales by Countries
9.1.2 Central & South America Human Chorionic Gonadotropin (HCG) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Human Chorionic Gonadotropin (HCG) by Product
9.3 Central & South America Human Chorionic Gonadotropin (HCG) by End User
10 Middle East and Africa
10.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) by Countries
10.1.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Countries
10.1.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) by Product
10.3 Middle East and Africa Human Chorionic Gonadotropin (HCG) by End User
11 Company Profiles
11.1 EMD Serono, Inc
11.1.1 EMD Serono, Inc Company Details
11.1.2 Company Business Overview
11.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Products Offered
11.1.5 EMD Serono, Inc Recent Development
11.2 Ferring B.V
11.2.1 Ferring B.V Company Details
11.2.2 Company Business Overview
11.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Ferring B.V Human Chorionic Gonadotropin (HCG) Products Offered
11.2.5 Ferring B.V Recent Development
11.3 Merck & Co., Inc
11.3.1 Merck & Co., Inc Company Details
11.3.2 Company Business Overview
11.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Products Offered
11.3.5 Merck & Co., Inc Recent Development
11.4 Bristol Myers Squibb Company
11.4.1 Bristol Myers Squibb Company Company Details
11.4.2 Company Business Overview
11.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Products Offered
11.4.5 Bristol Myers Squibb Company Recent Development
11.5 Fresenius Kabi AG, LLC
11.5.1 Fresenius Kabi AG, LLC Company Details
11.5.2 Company Business Overview
11.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Products Offered
11.5.5 Fresenius Kabi AG, LLC Recent Development
11.6 Scrippslabs
11.6.1 Scrippslabs Company Details
11.6.2 Company Business Overview
11.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Scrippslabs Human Chorionic Gonadotropin (HCG) Products Offered
11.6.5 Scrippslabs Recent Development
11.7 Leebio
11.7.1 Leebio Company Details
11.7.2 Company Business Overview
11.7.3 Leebio Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Leebio Human Chorionic Gonadotropin (HCG) Products Offered
11.7.5 Leebio Recent Development
11.8 Kamiya Biomedical Company
11.8.1 Kamiya Biomedical Company Company Details
11.8.2 Company Business Overview
11.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Products Offered
11.8.5 Kamiya Biomedical Company Recent Development
11.9 Sanzyme
11.9.1 Sanzyme Company Details
11.9.2 Company Business Overview
11.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sanzyme Human Chorionic Gonadotropin (HCG) Products Offered
11.9.5 Sanzyme Recent Development
11.10 Cigna
11.10.1 Cigna Company Details
11.10.2 Company Business Overview
11.10.3 Cigna Human Chorionic Gonadotropin (HCG) Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Cigna Human Chorionic Gonadotropin (HCG) Products Offered
11.10.5 Cigna Recent Development
12 Future Forecast
12.1 Human Chorionic Gonadotropin (HCG) Market Forecast by Regions
12.1.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Regions 2019-2025
12.1.2 Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Regions 2019-2025
12.2 Human Chorionic Gonadotropin (HCG) Market Forecast by Product
12.2.1 Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Product 2019-2025
12.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Product 2019-2025
12.3 Human Chorionic Gonadotropin (HCG) Market Forecast by End User
12.4 North America Human Chorionic Gonadotropin (HCG) Forecast
12.5 Europe Human Chorionic Gonadotropin (HCG) Forecast
12.6 Asia Pacific Human Chorionic Gonadotropin (HCG) Forecast
12.7 Central & South America Human Chorionic Gonadotropin (HCG) Forecast
12.8 Middle East and Africa Human Chorionic Gonadotropin (HCG) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Chorionic Gonadotropin (HCG) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Human Chorionic Gonadotropin (HCG) Product Picture
Table Human Chorionic Gonadotropin (HCG) Market Segments
Table Key Manufacturers Human Chorionic Gonadotropin (HCG) Covered
Table Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Product 2014-2025
Figure Natural Source Extraction Product Picture
Table Major Manufacturers of Natural Source Extraction
Figure Recombinant DNA Technology Product Picture
Table Major Manufacturers of Recombinant DNA Technology
Table Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Female Infertility Treatment
Figure Oligospermic Treatment
Figure Cryptorchidism Treatment
Figure Others
Figure Human Chorionic Gonadotropin (HCG) Report Years Considered
Figure Global Human Chorionic Gonadotropin (HCG) Market Size 2014-2025 (Million US$)
Figure Global Human Chorionic Gonadotropin (HCG) Sales 2014-2025 (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Human Chorionic Gonadotropin (HCG) Sales by Regions 2014-2019 (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Regions 2014-2019
Figure Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Regions 2014-2019
Figure 2018 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Regions
Table Global Human Chorionic Gonadotropin (HCG) Revenue by Regions 2014-2019 (Million US$)
Table Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Regions 2014-2019
Figure Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Regions 2014-2019
Figure 2018 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Regions
Table Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturers (2014-2019) (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Share by Manufacturers (2014-2019)
Figure Global Human Chorionic Gonadotropin (HCG) Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers (2014-2019) (Million USD)
Table Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers (2014-2019)
Figure Human Chorionic Gonadotropin (HCG) Value Share by Manufacturers in 2018
Table Key Manufacturers Human Chorionic Gonadotropin (HCG) Price (2014-2019) (USD/Unit)
Table Human Chorionic Gonadotropin (HCG) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Human Chorionic Gonadotropin (HCG) Product Type
Table Date of International Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Share by Product (2014-2019)
Figure Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Product in 2018
Table Global Human Chorionic Gonadotropin (HCG) Revenue by Product (2014-2019) (Million US$)
Table Global Human Chorionic Gonadotropin (HCG) Revenue Share by Product (2014-2019)
Figure Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Product (2014-2019)
Figure Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Product in 2018
Table Human Chorionic Gonadotropin (HCG) Price by Product 2014-2019 (USD/Unit)
Table Global Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Share by End User (2014-2019)
Figure Global Sales Human Chorionic Gonadotropin (HCG) Market Share by End User (2014-2019)
Figure Global Sales Human Chorionic Gonadotropin (HCG) Market Share by End User in 2018
Figure North America Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2014-2019 (K Units)
Figure North America Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2014-2019 (Million US$)
Table North America Human Chorionic Gonadotropin (HCG) Sales by Countries (2014-2019) (K Units)
Table North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2014-2019)
Figure 2018 North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries
Table North America Human Chorionic Gonadotropin (HCG) Revenue by Countries (2014-2019) (Million US$)
Table North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries
Figure United States Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure United States Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Canada Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Table North America Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure 2018 North America Human Chorionic Gonadotropin (HCG) Market Share by Product
Table North America Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table North America Human Chorionic Gonadotropin (HCG) Sales Market Share by End User (2014-2019)
Figure 2018 North America Human Chorionic Gonadotropin (HCG) Market Share by End User
Figure Europe Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2014-2019 (K Units)
Figure Europe Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Human Chorionic Gonadotropin (HCG) Sales by Countries (2014-2019) (K Units)
Table Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries
Table Europe Human Chorionic Gonadotropin (HCG) Revenue by Countries (2014-2019) (Million US$)
Table Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries
Figure Germany Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Germany Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure France Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure France Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure UK Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Italy Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Russia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure 2018 Europe Human Chorionic Gonadotropin (HCG) Market Share by Product
Table Europe Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by End User (2014-2019)
Figure 2018 Europe Human Chorionic Gonadotropin (HCG) Market Share by End User
Figure Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries
Figure China Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure China Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Japan Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Korea Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure India Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure India Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Australia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Share by Product
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Share by End User
Figure Central & South America Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales by Countries (2014-2019) (K Units)
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries
Table Central & South America Human Chorionic Gonadotropin (HCG) Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries
Figure Brazil Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Human Chorionic Gonadotropin (HCG) Market Share by Product
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table Central & South America Human Chorionic Gonadotropin (HCG) Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Human Chorionic Gonadotropin (HCG) Market Share by End User
Figure Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Countries
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Market Share by Countries
Figure GCC Countries Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Human Chorionic Gonadotropin (HCG) Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Human Chorionic Gonadotropin (HCG) Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Share by Product
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Share by End User
Table EMD Serono, Inc Company Details
Table EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table EMD Serono, Inc Recent Development
Table Ferring B.V Company Details
Table Ferring B.V Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Ferring B.V Recent Development
Table Merck & Co., Inc Company Details
Table Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co., Inc Recent Development
Table Bristol Myers Squibb Company Company Details
Table Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol Myers Squibb Company Recent Development
Table Fresenius Kabi AG, LLC Company Details
Table Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Fresenius Kabi AG, LLC Recent Development
Table Scrippslabs Company Details
Table Scrippslabs Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Scrippslabs Recent Development
Table Leebio Company Details
Table Leebio Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Leebio Recent Development
Table Kamiya Biomedical Company Company Details
Table Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Kamiya Biomedical Company Recent Development
Table Sanzyme Company Details
Table Sanzyme Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanzyme Recent Development
Table Cigna Company Details
Table Cigna Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cigna Recent Development
Table Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Regions 2019-2025 (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Market Share Forecast by Regions 2019-2025
Table Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Human Chorionic Gonadotropin (HCG) Revenue Market Share Forecast by Regions 2019-2025
Table Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Product 2019-2025 (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Market Share Forecast by Product 2019-2025
Table Global Human Chorionic Gonadotropin (HCG) Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Human Chorionic Gonadotropin (HCG) Revenue Market Share Forecast by Product 2019-2025
Table Global Human Chorionic Gonadotropin (HCG) Sales Forecast by End User 2019-2025 (K Units)
Table Global Human Chorionic Gonadotropin (HCG) Sales Market Share Forecast by End User 2019-2025
Figure North America Human Chorionic Gonadotropin (HCG) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Human Chorionic Gonadotropin (HCG) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Human Chorionic Gonadotropin (HCG) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Human Chorionic Gonadotropin (HCG) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Human Chorionic Gonadotropin (HCG) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Human Chorionic Gonadotropin (HCG) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Human Chorionic Gonadotropin (HCG) Value Chain
Table Human Chorionic Gonadotropin (HCG) Customers List
Table Human Chorionic Gonadotropin (HCG) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs